BANYU PHARMACEUTICAL CO., LTD.
|BANYU PHARMACEUTICAL CO., LTD. Patent applications|
|Patent application number||Title||Published|
|20110160208||DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE - The present invention provides the compounds represented by formula (I):||06-30-2011|
|20110144162||OXOTETRAHYDROFURAN-2-YL-BENZIMIDAZOLE DERIVATIVE - The present invention relates to compounds, which are useful for treatment and/or prevention of diabetes mellitus, diabetes mellitus complications or obesity, since the compounds have glucokinase-activating effects, and are presented in Formula (I): wherein R1 represents a carbamoyl group; R2 represents a lower alkyl group; both of X1 and X2 represent CH, or any one of X1 and X2 represents a nitrogen atom and the other represents CH; a group of represents a group selected from the group consisting of a pyridinyl, a pyrazinyl, a pyrazolyl, a thiadiazolyl, a triazolyl, an isoxazolyl and a thiazolyl group; and k is zero or 1, or relates to pharmaceutically acceptable salts thereof.||06-16-2011|
|20100130559||NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE - The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.||05-27-2010|
|20090258871||Aza-Substituted Spiro Derivatives - A compound of the following formula (I) or its pharmaceutically-acceptable salt is provided:||10-15-2009|
|20090209562||Fused ring 4-oxopyrimidine derivative - The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases.||08-20-2009|
|20090192174||Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action - The present invention relates to a compound of general formula I:||07-30-2009|
|20090118304||2-HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE - Disclosed is a compound represented by the formula (I) below, which has a glucokinase-activating effect and is thus useful for treatment of diabetes or obesity, or a pharmaceutically acceptable salt thereof.||05-07-2009|
Patent applications by BANYU PHARMACEUTICAL CO., LTD.